JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5926
ProShares Ultra Gold
UGL
$745M
| $27.8K | ﹤0.01% |
1,740
-68
| -4% | -$1.01K |
2023 Q2
2 quarters
|
|
5927
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.36B
| $27.7K | ﹤0.01% |
602
+542
| +903% | +$23.7K |
2022 Q3
5 quarters
|
|
5928
WisdomTree International High Dividend Fund
DTH
$625M
| $27.6K | ﹤0.01% |
709
+517
| +269% | +$19K |
2023 Q3
1 quarter
|
|
|
SLNO
5929
DELISTED
Soleno Therapeutics
SLNO
| $27.4K | ﹤0.01% |
681
-32,495
| -98% | -$924K |
2020 Q2
14 quarters
|
|
5930
Redwire
RDW
$2.64B
| $27.4K | ﹤0.01% |
9,614
+4,516
| +89% | +$12.3K |
2022 Q2
6 quarters
|
|
|
BHIL
5931
DELISTED
Benson Hill, Inc.
BHIL
| $26.9K | ﹤0.01% |
4,425
+54
| +1% | +$482 |
2021 Q3
9 quarters
|
|
5932
Rekor Systems
REKR
$52.7M
| $26.9K | ﹤0.01% |
8,077
| – | – |
2021 Q2
10 quarters
|
|
5933
Anixa Biosciences
ANIX
$96.3M
| $26.6K | ﹤0.01% |
6,857
-20,432
| -75% | -$68.9K |
2017 Q2
26 quarters
|
|
|
PBT
5934
Permian Basin Royalty Trust
PBT
$1.46B
| $26.5K | ﹤0.01% |
1,900
-2,927
| -61% | -$52.4K |
2020 Q4
12 quarters
|
|
5935
Owlet
OWLT
$147M
| $26.4K | ﹤0.01% |
5,009
+5,003
| +83,383% | +$24.5K |
2021 Q3
9 quarters
|
|
5936
Invesco CurrencyShares Japanese Yen Trust
FXY
$461M
| $26.3K | ﹤0.01% |
400
| – | – |
2023 Q2
2 quarters
|
|
|
BBSA
5937
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
| $26.2K | ﹤0.01% |
547
+315
| +136% | +$14.8K |
2019 Q2
18 quarters
|
|
|
AE
5938
DELISTED
Adams Resources & Energy Inc
AE
| $26.2K | ﹤0.01% |
1,000
| – | – |
2022 Q4
4 quarters
|
|
|
CCD
5939
Calamos Dynamic Convertible & Income Fund
CCD
$643M
| $26K | ﹤0.01% |
+1,315
| New | +$24.5K |
2023 Q4
0 quarters
|
|
|
BPT
5940
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $25.9K | ﹤0.01% |
+10,500
| New | +$42.7K |
2023 Q4
0 quarters
|
|
|
OKUR
5941
OnKure Therapeutics
OKUR
$103M
| $25.9K | ﹤0.01% |
1,618
+763
| +89% | +$47.5K |
2022 Q3
5 quarters
|
|
5942
First Trust SSI Strategic Convertible Securities ETF
FCVT
$103M
| $25.8K | ﹤0.01% |
+773
| New | +$24.1K |
2023 Q4
0 quarters
|
|
5943
Pacer Trendpilot 100 ETF
PTNQ
$1.29B
| $25.8K | ﹤0.01% |
394
+11
| +3% | +$699 |
2023 Q1
3 quarters
|
|
5944
Davis Select US Equity ETF
DUSA
$1.23B
| $25.7K | ﹤0.01% |
+730
| New | +$24.1K |
2023 Q4
0 quarters
|
|
|
VGI
5945
Virtus Global Multi-Sector Income Fund
VGI
$75.8M
| $25.5K | ﹤0.01% |
3,262
-1,740
| -35% | -$12.6K |
2023 Q3
1 quarter
|
|
|
CMAX
5946
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $25.5K | ﹤0.01% |
1,703
-52,795
| -97% | -$2.19M |
2021 Q4
8 quarters
|
|
5947
PUT
Northern Trust
NTRS
$31B
| $25.3K | ﹤0.01% |
+300
| New | +$22.2K |
2023 Q4
0 quarters
|
|
|
PRLH
5948
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
| $25.2K | ﹤0.01% |
+2,352
| New | +$25.3K |
2023 Q4
0 quarters
|
|
5949
PUT
ON Semiconductor
ON
$31.2B
| $25.1K | ﹤0.01% |
300
| – | – |
2022 Q4
4 quarters
|
|
5950
Jaguar Health
JAGX
$2.05M
| – | – |
0
| – | – |
2021 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.